Cigna (CI) Upgraded, Anthem (ANTM) Downgraded by Morgan Stanley on Biosimilar Humira Opportunity

June 22, 2022 1:40 PM EDT Send to a Friend
Morgan Stanley analyst Ricky Goldwasser said in a client note Wednesday that the firm is upgrading Cigna Corporation (NYSE: CI) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login